• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病及相关疾病中的自噬途径。

Autophagic pathways in Parkinson disease and related disorders.

机构信息

Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.

出版信息

Expert Rev Mol Med. 2011 Mar 21;13:e8. doi: 10.1017/S1462399411001803.

DOI:10.1017/S1462399411001803
PMID:21418705
Abstract

Macroautophagy and chaperone-mediated autophagy (CMA) are the two main mammalian lysosomal proteolytic systems. In macroautophagy, double-membrane structures engulf organelles and other intracellular constituents through a highly regulated process that involves the formation of autophagic vacuoles and their fusion with lysosomes. In CMA, selected proteins are targeted through a nonvesicular pathway to a transport complex at the lysosomal membrane, through which they are threaded into the lysosomes and degraded. Autophagy is important in development, differentiation, cellular remodelling and survival during nutrient starvation. Increasing evidence suggests that autophagic dysregulation causes accumulation of abnormal proteins or damaged organelles, which is a characteristic of chronic neurodegenerative conditions, such as Parkinson disease (PD). Evidence from post-mortem material, transgenic mice, and animal and cellular models of PD suggests that both major autophagic pathways are malfunctioning. Numerous connections exist between proteins genetically linked to autosomal dominant PD, in particular α-synuclein and LRRK2, and autophagic pathways. However, proteins involved in recessive PD, such as PINK1 and Parkin (PINK2), function in the process of mitophagy, whereby damaged mitochondria are selectively engulfed by macroautophagy. This wealth of new data suggests that both autophagic pathways are potential targets for therapeutic intervention in PD and other related neurodegenerative conditions.

摘要

自噬和伴侣介导的自噬(CMA)是哺乳动物溶酶体蛋白水解系统的两种主要形式。在自噬中,双层膜结构通过一个高度调控的过程吞噬细胞器和其他细胞内成分,这个过程涉及自噬小泡的形成和与溶酶体的融合。在 CMA 中,通过非囊泡途径将选定的蛋白质靶向溶酶体膜上的运输复合物,通过该复合物将它们穿入溶酶体并降解。自噬在发育、分化、细胞重塑和营养饥饿时的存活中起着重要作用。越来越多的证据表明,自噬失调会导致异常蛋白质或受损细胞器的积累,这是慢性神经退行性疾病(如帕金森病)的特征。来自尸检材料、转基因小鼠以及帕金森病的动物和细胞模型的证据表明,两种主要的自噬途径都存在功能障碍。与常染色体显性遗传帕金森病相关的许多蛋白质(特别是α-突触核蛋白和 LRRK2)与自噬途径之间存在许多联系。然而,涉及隐性帕金森病的蛋白质,如 PINK1 和 Parkin(PINK2),在细胞的线粒体自噬过程中发挥作用,即受损的线粒体被自噬选择性吞噬。大量新数据表明,自噬途径可能是帕金森病和其他相关神经退行性疾病治疗干预的潜在靶点。

相似文献

1
Autophagic pathways in Parkinson disease and related disorders.帕金森病及相关疾病中的自噬途径。
Expert Rev Mol Med. 2011 Mar 21;13:e8. doi: 10.1017/S1462399411001803.
2
Chaperone-mediated autophagy in aging and disease.伴侣介导的自噬与衰老和疾病
Curr Top Dev Biol. 2006;73:205-35. doi: 10.1016/S0070-2153(05)73007-6.
3
Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives.神经退行性疾病中自噬的失调——最新进展与未来展望。
J Neurochem. 2011 Aug;118(3):317-25. doi: 10.1111/j.1471-4159.2011.07314.x. Epub 2011 Jun 17.
4
Aging: central role for autophagy and the lysosomal degradative system.衰老:自噬和溶酶体降解系统的核心作用。
Ageing Res Rev. 2009 Jul;8(3):199-213. doi: 10.1016/j.arr.2009.05.001. Epub 2009 May 7.
5
Genetic causes of Parkinson's disease and their links to autophagy regulation.帕金森病的遗传病因及其与自噬调控的关系。
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S154-7. doi: 10.1016/S1353-8020(13)70037-3.
6
Parkinson disease: a role for autophagy?帕金森病:自噬的作用?
Neuroscientist. 2010 Aug;16(4):335-41. doi: 10.1177/1073858409357118. Epub 2010 Apr 1.
7
Regulation and role of autophagy in mammalian cells.自噬在哺乳动物细胞中的调控及作用
Int J Biochem Cell Biol. 2004 Dec;36(12):2445-62. doi: 10.1016/j.biocel.2004.02.002.
8
A new perspective in Parkinson's disease, chaperone-mediated autophagy.帕金森病的新视角:伴侣介导的自噬。
Parkinsonism Relat Disord. 2011 May;17(4):231-5. doi: 10.1016/j.parkreldis.2010.12.008. Epub 2011 Jan 7.
9
Pathophysiology of chaperone-mediated autophagy.伴侣蛋白介导的自噬的病理生理学
Int J Biochem Cell Biol. 2004 Dec;36(12):2420-34. doi: 10.1016/j.biocel.2004.04.010.
10
Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases.伴侣介导的自噬来救援:治疗神经退行性疾病的一个新奇靶点。
Mol Cell Neurosci. 2015 May;66(Pt A):29-36. doi: 10.1016/j.mcn.2015.01.003. Epub 2015 Feb 25.

引用本文的文献

1
Chaperone mediated autophagy modulates microglia polarization and inflammation via LAMP2A in ischemia induced spinal cord injury.伴侣介导的自噬通过LAMP2A调节缺血性脊髓损伤中微胶质细胞的极化和炎症反应。
Toxicol Res (Camb). 2025 Apr 29;14(2):tfaf061. doi: 10.1093/toxres/tfaf061. eCollection 2025 Apr.
2
Neurotoxic Effects of Atrazine on Dopaminergic System via miRNAs and Energy-Sensing Pathways.阿特拉津通过微小RNA和能量感应途径对多巴胺能系统产生神经毒性作用。
Mol Neurobiol. 2025 Mar 14. doi: 10.1007/s12035-025-04822-8.
3
AMPK Signaling Pathway as a Potential Therapeutic Target for Parkinson's Disease.
AMPK信号通路作为帕金森病的潜在治疗靶点
Adv Pharm Bull. 2024 Mar;14(1):120-131. doi: 10.34172/apb.2024.013. Epub 2023 Oct 14.
4
Gut-Brain Axis Modulation of Metabolic Disorders: Exploring the Intertwined Neurohumoral Pathways and Therapeutic Prospects.肠道-大脑轴对代谢紊乱的调节:探索相互交织的神经激素途径和治疗前景。
Neurochem Res. 2024 Apr;49(4):847-871. doi: 10.1007/s11064-023-04084-7. Epub 2024 Jan 20.
5
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson's Disease Pathogenesis.胰岛素抵抗与帕金森病发病机制关系的分子机制。
Nutrients. 2023 Aug 15;15(16):3585. doi: 10.3390/nu15163585.
6
Multifunctional role of natural products for the treatment of Parkinson's disease: At a glance.天然产物在帕金森病治疗中的多功能作用:概述
Front Pharmacol. 2022 Oct 6;13:976385. doi: 10.3389/fphar.2022.976385. eCollection 2022.
7
Investigating p62 Concentrations in Cerebrospinal Fluid of Patients with Dementia: A Potential Autophagy Biomarker In Vivo?研究痴呆患者脑脊液中p62的浓度:一种潜在的体内自噬生物标志物?
Brain Sci. 2022 Oct 20;12(10):1414. doi: 10.3390/brainsci12101414.
8
Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration.神经炎症上调神经元Toll样受体2和4以驱动神经退行性疾病中的α-突触核蛋白病。
Front Pharmacol. 2022 Mar 24;13:845930. doi: 10.3389/fphar.2022.845930. eCollection 2022.
9
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease.α-突触核蛋白在帕金森病炎症性突触病中的突出作用。
Int J Mol Sci. 2021 Jun 17;22(12):6517. doi: 10.3390/ijms22126517.
10
Microglia in Neurodegenerative Events-An Initiator or a Significant Other?神经退行性事件中的小胶质细胞——始作俑者还是重要参与者?
Int J Mol Sci. 2021 May 29;22(11):5818. doi: 10.3390/ijms22115818.